Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization, a ...

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet in Sweden shows that some immune cells with high inflammatory potential ...

The risk for fertility treatment rose among women with vs. without asthma, and those with severe asthma and past exacerbations faced a greater risk, according to data published in The Journal of ...

Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated with oral corticosteroid sparing in the phase III SOURCE trial, which ...

AZ showed that use of inhaler Airsupra in those with mild asthma reduced the risk of severe exacerbations by 47% compared to albuterol.

As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to ...

Australia’s new asthma guidelines warn against anyone with asthma – even those with infrequent symptoms – using only salbutamol inhaler.

Adial Pharmaceuticals announces a milestone payment from Adovate, LLC, following the launch of a Phase 1 trial for asthma treatment.

(RTTNews) - AstraZeneca Plc.'s (AZN.L, AZN) triple-combination inhaler, Breztri Aerosphere, has shown positive results in late-stage clinical trials for patients with uncontrolled asthma. The ...

Recent research suggests that the biologic medications benralizumab and dupilumab can help treat emphysema. Learn more here.